triggered peptides semaglutide Peptide of the Week: Peptide: A Promising Advancement in Diabetes Treatment Peptides: What they are, potential

The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefitrisk relationship

GLP-1 receptors exist in brain regions affected by Parkinson's, prompting clinical trials to explore whether these agents might slow disease progression or improve motor symptoms

Study evidence showed an an inverse association between use of DPP-4 inhibitors and GLP-1 mimetics and the onset of Parkinson's disease 3

That fluid loss may lower the number on the scale temporarily, but it does not reduce stored body fat or change calorie absorption